MPNs | Clinical

Interferon Use in Patients with Myeloproliferative Neoplasms

January 11, 2022

Richard T. Silver, MD, discusses which patients with myeloproliferative neoplasms may derive the most benefit from recombinant interferon alpha, based on prior research in the chronic myeloid leukemia space and in patients with myeloproliferative neoplasms.

The Expanding Role of Interferons in Myeloproliferative Neoplasms

November 24, 2021

In an interview with Targeted Oncology™, Richard T. Silver, MD, discussed the role of interferon in the treatment of myeloproliferative neoplasm as well as the importance of the 3-year global MPN initiative being conducted by the MPN Research Foundation.